Genetics of HIV-associated sensory neuropathy and related pain in Africans Huguette Gaelle Ngassa MbendaAntonia WadleyPeter Kamerman Review 30 May 2017 Pages: 511 - 519
Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus Nicole ArnoldChristine MeyerIlhem Messaoudi OriginalPaper 20 March 2017 Pages: 520 - 538
White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration Lucette A. CysiqueJames R. SoaresCaroline Rae OriginalPaper 21 March 2017 Pages: 539 - 547
Erratum to: White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration Lucette A. CysiqueJames R. SoaresCaroline Rae Erratum 28 July 2017 Pages: 548 - 549
The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV Joseph D. HarrisonJessica A. DochneyRebecca L. Ashare OriginalPaper 20 April 2017 Pages: 550 - 557
Association of long-term patterns of depressive symptoms and attention/executive function among older men with and without human immunodeficiency virus Nicole M. ArmstrongPamela J. SurkanAlison G. Abraham OriginalPaper 20 April 2017 Pages: 558 - 567
An oral form of methylglyoxal-bis-guanylhydrazone reduces monocyte activation and traffic to the dorsal root ganglia in a primate model of HIV-peripheral neuropathy Jessica R. LakritzSamshita YalamanchiliTricia H. Burdo OriginalPaper 01 May 2017 Pages: 568 - 576
Modeling brain lentiviral infections during antiretroviral therapy in AIDS Weston C. RodaMichael Y. LiChristopher Power OriginalPaper 16 May 2017 Pages: 577 - 586
The EGF epidermal growth factor counteracts Tat modulation of human endogenous retroviruses of the W family in astrocytes Elena UleriClaudia PiuAntonina Dolei Short Communication 04 May 2017 Pages: 587 - 592
Improvements in brain and behavior following eradication of hepatitis C Taylor KuhnPhilip SayeghCharles H. Hinkin OriginalPaper 30 May 2017 Pages: 593 - 602
Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS Rahul Dev JayantVenkata S. R. AtluriMadhavan Nair OriginalPaper 31 July 2017 Pages: 603 - 614
Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient A. VelayW. Kack-KackH. Barth Case Report 24 April 2017 Pages: 615 - 620
Diplopia as isolated presentation of varicella zoster central nervous system reactivation Cosmo Del BorgoValeria BelvisiClaudio Maria Mastroianni Case Report 30 May 2017 Pages: 621 - 624
Immunoglobulin-responsive chikungunya encephalitis: two case reports Stephanie Suzanne de O. ScottPedro Braga-NetoClaudia Carvalho Mendes Schiavon Case Report 02 June 2017 Pages: 625 - 631
Progressive multifocal leukoencephalopathy in a patient with lymphoma and presumptive hyper IgE syndrome Rahsan GocmenNazire Pinar AcarAsli Kurne Case Report 22 June 2017 Pages: 632 - 636
Erratum to: Acyclovir resistance in herpes simplex virus type I encephalitis: a case report M. BergmannR. BeerE. Schmutzhard Erratum 29 June 2017 Pages: 637 - 637
Acyclovir resistance in herpes simplex virus type I encephalitis: a case report Andreas Sauerbrei Letter to the Editor 21 June 2017 Pages: 638 - 639
Response to the letter to the editor by Andreas Sauerbrei on “Acyclovir resistance in herpes simplex type I encephalitis, a case report” Erich SchmutzhardMelanie BergmannBettina Pfausler Letter to the Editor 05 July 2017 Pages: 640 - 641
2017 Colorado alphaherpesvirus latency society symposium Nicholas L. BairdRandall J. Cohrs Meeting Report 07 August 2017 Pages: 642 - 655
